Retraction notice to "Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5/CXCR4, Orai-1/STIM-1 signaling pathways" [Int. Immunopharmacol. 140 (2024) 112777].

El-Shoura EAM, Mohamed AAN, Atwa AM, Salem EA, Sharkawi SMZ, Selim HM, Elberri AI, Gawesh ES, Ahmed YH, Abd El-Ghafar OAM

Open source

DOI
10.1016/j.intimp.2026.117334
Published
2026 Sep 19
Container
International immunopharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.117334,
  title = {Retraction notice to "Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5/CXCR4, Orai-1/STIM-1 signaling pathways" [Int. Immunopharmacol. 140 (2024) 112777].},
  author = {El-Shoura EAM and Mohamed AAN and Atwa AM and Salem EA and Sharkawi SMZ and Selim HM and Elberri AI and Gawesh ES and Ahmed YH and Abd El-Ghafar OAM},
  year = {2026},
  journal = {International immunopharmacology},
  doi = {10.1016/j.intimp.2026.117334},
  url = {https://doi.org/10.1016/j.intimp.2026.117334}
}

RIS

TY  - JOUR
TI  - Retraction notice to "Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5/CXCR4, Orai-1/STIM-1 signaling pathways" [Int. Immunopharmacol. 140 (2024) 112777].
AU  - El-Shoura EAM
AU  - Mohamed AAN
AU  - Atwa AM
AU  - Salem EA
AU  - Sharkawi SMZ
AU  - Selim HM
AU  - Elberri AI
AU  - Gawesh ES
AU  - Ahmed YH
AU  - Abd El-Ghafar OAM
PY  - 2026
JO  - International immunopharmacology
DO  - 10.1016/j.intimp.2026.117334
UR  - https://doi.org/10.1016/j.intimp.2026.117334
ER  - 

APA

EAM, E., AAN, M., AM, A., EA, S., SMZ, S., HM, S., AI, E., ES, G., YH, A., & OAM, A. E. (2026). Retraction notice to "Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5/CXCR4, Orai-1/STIM-1 signaling pathways" [Int. Immunopharmacol. 140 (2024) 112777].. International immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117334

Source records